Shares of Relypsa surged Thursday on news that Galenica, the owner of Switzerland’s largest pharmacy network, has made a $1.53 billion takeover offer for the company. The $32 a share offer represents a 59 percent premium to Wednesday’s closing price for Relypsa. The company makes Veltassa, the first new medicine in 50 years for treating excessive levels of potassium in the blood.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
